Vendor, Austin, TX
Veloxai LLC
UEI L267GZS3JE28, CAGE 8DMU1
1 award and $0 obligated between August 24, 2026 and August 24, 2026, 100% under full and open competition, against 3.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91024C00073Definitive Contract, August 24, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | NIH NCINational Institutes of Health | Eo 14398 SBIR Phase Ii, Topic 431: Automatic Treatment Planning of Cervical Cancer High-Dose Rate Brachytherpay for Low-Resource Settings.NAICS 541715, PSC AN12 | $0 |
- Places of performance
- Texas
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards